Latest news with #Yen1
Business Insider
13 hours ago
- Business
- Business Insider
Santen Pharmaceutical Co (SNPHF) was downgraded to a Hold Rating at Jefferies
Jefferies analyst Stephen Barker downgraded Santen Pharmaceutical Co to a Hold on August 8 and set a price target of Yen1,700.00. The company's shares closed last Wednesday at $11.45. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Barker covers the Healthcare sector, focusing on stocks such as Sumitomo Dainippon Pharma Co, Eisai Co, and Otsuka Holdings Co. According to TipRanks, Barker has an average return of 10.6% and a 52.63% success rate on recommended stocks. Currently, the analyst consensus on Santen Pharmaceutical Co is a Moderate Buy with an average price target of $14.56. Based on Santen Pharmaceutical Co's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $77.23 billion and a net profit of $8.78 billion. In comparison, last year the company earned a revenue of $79.13 billion and had a net profit of $29 million
Business Insider
2 days ago
- Business
- Business Insider
Bernstein Remains a Hold on SUMCO Corporation (3436)
In a report released today, David Dai CFA from Bernstein maintained a Hold rating on SUMCO Corporation. The company's shares closed today at Yen1,218.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Dai CFA covers the Technology sector, focusing on stocks such as ASML Holding NV, Advantest, and SCREEN Holdings Co. According to TipRanks, Dai CFA has an average return of -3.5% and a 31.43% success rate on recommended stocks. Currently, the analyst consensus on SUMCO Corporation is a Moderate Buy with an average price target of Yen1,360.00. 3436 market cap is currently Yen420B and has a P/E ratio of 40.55.
Business Insider
03-08-2025
- Business
- Business Insider
Sumitomo Dainippon Pharma Co (DNPUF) Gets a Buy from Jefferies
Jefferies analyst Stephen Barker maintained a Buy rating on Sumitomo Dainippon Pharma Co on August 1 and set a price target of Yen1,600.00. The company's shares closed last Thursday at $7.24. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Barker covers the Healthcare sector, focusing on stocks such as Sumitomo Dainippon Pharma Co, Otsuka Holdings Co, and Eisai Co. According to TipRanks, Barker has an average return of 8.8% and a 51.35% success rate on recommended stocks. In addition to Jefferies, Sumitomo Dainippon Pharma Co also received a Buy from J.P. Morgan's Seiji Wakao in a report issued on July 30. However, on July 31, TR | OpenAI – 4o reiterated a Hold rating on Sumitomo Dainippon Pharma Co (Other OTC: DNPUF). Based on Sumitomo Dainippon Pharma Co's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $105.65 billion and a net profit of $2.42 billion. In comparison, last year the company earned a revenue of $79.53 billion and had a GAAP net loss of $197.26 billion
Business Insider
09-07-2025
- Business
- Business Insider
Jefferies Reaffirms Their Buy Rating on Sumitomo Dainippon Pharma Co (DNPUF)
In a report released today, Stephen Barker from Jefferies maintained a Buy rating on Sumitomo Dainippon Pharma Co, with a price target of Yen1,300.00. The company's shares closed yesterday at $6.34. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Barker is a 3-star analyst with an average return of 2.9% and a 47.06% success rate. Barker covers the Healthcare sector, focusing on stocks such as Sumitomo Dainippon Pharma Co, Astellas Pharma, and Asahi Intecc Co. The word on The Street in general, suggests a Hold analyst consensus rating for Sumitomo Dainippon Pharma Co with a $5.93 average price target.
Business Insider
05-07-2025
- Business
- Business Insider
Jefferies Sticks to Its Buy Rating for JX Advanced Metals Corporation (5016)
Jefferies analyst Thanh Ha Pham maintained a Buy rating on JX Advanced Metals Corporation yesterday and set a price target of Yen970.00. The company's shares closed yesterday at Yen818.90. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Ha Pham is a 3-star analyst with an average return of 5.4% and a 60.00% success rate. Ha Pham covers the Basic Materials sector, focusing on stocks such as JX Advanced Metals Corporation, Daido Steel Co, and Dowa Holdings Co. JX Advanced Metals Corporation has an analyst consensus of Moderate Buy, with a price target consensus of Yen950.00. The company has a one-year high of Yen1,040.00 and a one-year low of Yen433.00. Currently, JX Advanced Metals Corporation has an average volume of 8.21M.
